Cilnidipine Sartel LN INN is a calcium channel blocker Cilnidipine Sartel LN is the novel calcium antagonist accompanied with L type and N type calcium channel blocking function It was jointly developed by Fuji Viscera Pharmaceutical Company Japan and Ajinomoto Japan and approved to come into market for the first time and used for high blood pressure treatment in 1995 Compared with other calcium antagonists Cilnidipine Sartel LN can act on the N type calcium channel that existing sympathetic nerve end besides acting on L type calcium channel that similar to most of the calcium antagonists Cilnidipine Sartel LN is approved for use in Japan China India Korea and some European countries

Sartel LN 40 Tablet 10 s should be taken with caution in patients with congestive heart failure liver disease peripheral oedema swelling of hands legs cardiogenic shock when heart suddenly can not pump sufficient blood recent MI myocardial infarction or acute unstable angina chest pain severe aortic stenosis when heart valves become diseased You should monitor your blood pressure regularly to make sure the Sartel LN 40 Tablet 10 s is working efficiently Besides this prolonged intake of Sartel LN 40 Tablet 10 s can lead to lowering of blood pressure hypotension So daily monitoring of blood pressure is advisable